Powered by

Intec Pharma Announces Fourth Quarter and Year End 2017 Financial Results

Mar 09, 2018 - Marketline Newswire
Board and Executive Moves-Financial Results

Intec Pharma LTD. reported that its comprehensive loss attributable to common stockholders for the fourth quarter of 2017 was approximately $10.2 million, an increase of $6.6 million, or approximately 183%, compared to the Company's comprehensive loss for the fourth quarter of 2016 of approximately $3.6 million. The comprehensive loss attributable to common stockholders for the full-year 2017 was approximately $29.1 million, an increase of $15.7 million, or approximately 117%, compared to the Co...